Nevertheless, other tumour types that frequently harbour an IDH mutation do show the prognostic value of the IDH mutation (glioma) and response to IDHMUT protein inhibitors (AML) (Table 1). The gene discussed is IDH1; the disease is acute myeloid leukemia.